PE_PGRS33, an Important Virulence Factor of


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
15 01 2021
Historique:
received: 17 11 2020
revised: 04 01 2021
accepted: 12 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 9 7 2021
Statut: epublish

Résumé

PE_PGRS proteins are surface antigens of

Identifiants

pubmed: 33467487
pii: cells10010161
doi: 10.3390/cells10010161
pmc: PMC7830552
pii:
doi:

Substances chimiques

Antigens 0
Antigens, Bacterial 0
Antigens, Surface 0
Bacterial Proteins 0
Membrane Proteins 0
PE-PGRS protein, Mycobacterium 0
TLR2 protein, human 0
Toll-Like Receptor 2 0
Tuberculosis Vaccines 0
Virulence Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

FEMS Microbiol Rev. 2012 May;36(3):514-32
pubmed: 22320122
Future Microbiol. 2015;10(7):1177-94
pubmed: 26119086
Biophys J. 2013 Jun 4;104(11):2530-9
pubmed: 23746526
N Engl J Med. 2017 Jan 19;376(3):283-285
pubmed: 28099836
Biotechnol Appl Biochem. 2015 Mar-Apr;62(2):145-53
pubmed: 24975480
MethodsX. 2014 Aug 19;1:124-9
pubmed: 26150943
Lancet. 2013 Mar 23;381(9871):1021-8
pubmed: 23391465
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
Mol Microbiol. 2007 Dec;66(6):1536-47
pubmed: 18028308
Infect Immun. 2001 Dec;69(12):7326-33
pubmed: 11705904
J Immunol. 2013 Jun 15;190(12):6311-9
pubmed: 23677471
Pathog Dis. 2017 Nov 30;75(8):
pubmed: 28911035
Scand J Immunol. 2016 Oct;84(4):204-10
pubmed: 27454335
Hum Vaccin Immunother. 2018 Jul 3;14(7):1697-1716
pubmed: 29601253
J Am Chem Soc. 2008 Jul 30;130(30):9695-701
pubmed: 18598029
BMC Evol Biol. 2006 Nov 15;6:95
pubmed: 17105670
Int J Mycobacteriol. 2015 Mar;4(1):73-9
pubmed: 26655202
Mol Microbiol. 2002 Apr;44(1):9-19
pubmed: 11967065
Annu Rev Biophys Biomol Struct. 2000;29:291-325
pubmed: 10940251
Microbiology (Reading). 1999 Dec;145 ( Pt 12):3487-3495
pubmed: 10627046
Cell Host Microbe. 2015 Nov 11;18(5):538-48
pubmed: 26607161
Mol Microbiol. 2014 Oct;94(2):367-82
pubmed: 25155747
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Infect Immun. 2009 Aug;77(8):3337-43
pubmed: 19487480
J Mol Biol. 2013 Jun 26;425(12):2100-32
pubmed: 23507311
Front Immunol. 2017 Dec 15;8:1803
pubmed: 29326700
Front Immunol. 2014 May 27;5:236
pubmed: 24904584
Front Immunol. 2017 Sep 19;8:1147
pubmed: 28974949
Vaccine. 2015 Aug 7;33(33):4130-40
pubmed: 26095509
PLoS One. 2011;6(11):e27713
pubmed: 22110736
Virulence. 2020 Dec;11(1):898-915
pubmed: 32713249
mBio. 2019 Oct 29;10(5):
pubmed: 31662454
Microbes Infect. 2006 Jul;8(8):2061-7
pubmed: 16798044
Tuberculosis (Edinb). 2007 Jul;87(4):338-46
pubmed: 17475562
Lancet Infect Dis. 2020 Mar;20(3):e28-e37
pubmed: 32014117
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11342-7
pubmed: 22733768
FEBS J. 2015 Jul;282(13):2500-11
pubmed: 25846449
Lancet Respir Med. 2018 Apr;6(4):287-298
pubmed: 29595510
PLoS One. 2010 Nov 11;5(11):e13938
pubmed: 21085642
BMC Med. 2016 Sep 15;14(1):138
pubmed: 27633883
Biochim Biophys Acta. 2016 Feb;1860(2):445-51
pubmed: 26549874
Int J Infect Dis. 2017 Mar;56:263-267
pubmed: 27816661
J Infect Dis. 2016 Jul 15;214(2):300-10
pubmed: 27056953
Am J Respir Crit Care Med. 2013 Aug 15;188(4):492-502
pubmed: 23306546
Nat Rev Immunol. 2019 Sep;19(9):550-562
pubmed: 31114037
Vaccine. 2010 Jan 22;28(4):1106-16
pubmed: 19853680
Clin Infect Dis. 2018 Feb 1;66(4):554-563
pubmed: 29028973
Expert Rev Vaccines. 2014 Aug;13(8):927-30
pubmed: 24935214
Infect Immun. 2001 Jun;69(6):4185-91
pubmed: 11349098
J Immunol. 2010 Apr 1;184(7):3495-504
pubmed: 20176745
Chemistry. 2018 Feb 21;24(11):2533-2546
pubmed: 28925518
Lancet Infect Dis. 2016 Apr;16(4):408-9
pubmed: 27036342
mBio. 2014 Jan 14;5(1):e00960-13
pubmed: 24425732
J Immunol. 2011 Nov 1;187(9):4744-53
pubmed: 21957139
PLoS One. 2017 Apr 28;12(4):e0176784
pubmed: 28453555
Clin Infect Dis. 2014 Feb;58(4):470-80
pubmed: 24336911
Curr Med Chem. 2015;22(14):1698-709
pubmed: 25666798
Expert Rev Vaccines. 2015 May;14(5):699-711
pubmed: 25693607
Cell Host Microbe. 2017 Jun 14;21(6):695-706.e5
pubmed: 28618268
mBio. 2018 Jun 19;9(3):
pubmed: 29921671
Semin Immunopathol. 2020 Jun;42(3):315-331
pubmed: 32189035
Mediterr J Hematol Infect Dis. 2013 Nov 16;5(1):e2013070
pubmed: 24363885
Nature. 1998 Jun 11;393(6685):537-44
pubmed: 9634230
J Phys Chem B. 2010 May 20;114(19):6636-41
pubmed: 20415491
Microb Pathog. 2009 Mar;46(3):119-27
pubmed: 19068228
J Biol Chem. 2017 Oct 13;292(41):16880-16890
pubmed: 28842489
J Med Microbiol. 2007 Apr;56(Pt 4):466-474
pubmed: 17374885
Trends Microbiol. 2002 May;10(5):246-9
pubmed: 11973159
Lancet Respir Med. 2020 Jan;8(1):19
pubmed: 31706931
Clin Microbiol Infect. 2014 May;20 Suppl 5:59-65
pubmed: 24283256
F1000Res. 2018 Nov 1;7:1732
pubmed: 30613395
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
PLoS One. 2017 May 12;12(5):e0175215
pubmed: 28498853
Structure. 2018 Dec 4;26(12):1573-1582.e4
pubmed: 30244968
Tuberculosis (Edinb). 2016 Mar;97:163-71
pubmed: 26750180
PLoS Pathog. 2016 Jul 28;12(7):e1005770
pubmed: 27467705
J Clin Invest. 2020 Apr 1;130(4):1808-1822
pubmed: 31935198
J Infect Dis. 2016 Aug 1;214(3):426-37
pubmed: 27234419
Front Cell Infect Microbiol. 2017 Apr 21;7:137
pubmed: 28484686
J Infect. 2010 May;60(5):320-30
pubmed: 20156481
Nat Genet. 2010 Jun;42(6):498-503
pubmed: 20495566
Microbes Infect. 2007 Mar;9(3):271-81
pubmed: 17223373
Nat Rev Microbiol. 2009 Dec;7(12):845-55
pubmed: 19855401
PLoS One. 2011;6(9):e23826
pubmed: 21909406
Lancet Respir Med. 2019 Sep;7(9):820-826
pubmed: 31486393
Front Cell Infect Microbiol. 2016 May 02;6:49
pubmed: 27200304
Protein Sci. 2000 Sep;9(9):1753-73
pubmed: 11045621
Scand J Immunol. 2018 Oct;88(4):e12710
pubmed: 30175850
J Clin Microbiol. 2011 Jul;49(7):2719-21
pubmed: 21525214
Microbes Infect. 2006 Jan;8(1):262-72
pubmed: 16203168
PLoS One. 2011 Feb 10;6(2):e16745
pubmed: 21347309
FEBS Lett. 2014 Mar 18;588(6):990-4
pubmed: 24530527
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8060-5
pubmed: 16690741
Mol Microbiol. 2004 May;52(3):725-33
pubmed: 15101979
J Biol Chem. 2007 Jan 12;282(2):1039-50
pubmed: 17095513
Med J Armed Forces India. 2019 Jan;75(1):18-24
pubmed: 30705473
PLoS One. 2016 Mar 15;11(3):e0150800
pubmed: 26978522
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21780-21788
pubmed: 31591215
Tuberculosis (Edinb). 2016 Dec;101:164-173
pubmed: 27865389
Microbiol Spectr. 2014 Feb;2(1):MGM2-0028-2013
pubmed: 26082111
Blood. 2017 Aug 31;130(9):1104-1113
pubmed: 28646118
Semin Immunol. 2014 Dec;26(6):601-9
pubmed: 25453231
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14758-63
pubmed: 25275011
Nat Med. 2019 Jun;25(6):977-987
pubmed: 31110348
J Mol Microbiol Biotechnol. 2011;21(3-4):97-109
pubmed: 22286037
Trans R Soc Trop Med Hyg. 2016 Apr;110(4):212-8
pubmed: 27076508
Structure. 2018 Dec 4;26(12):1565-1567
pubmed: 30517883
PLoS Pathog. 2017 Mar 9;13(3):e1006250
pubmed: 28278283

Auteurs

Eliza Kramarska (E)

Institute of Biostructures and Bioimaging, IBB, CNR, 80134 Naples, Italy.

Flavia Squeglia (F)

Institute of Biostructures and Bioimaging, IBB, CNR, 80134 Naples, Italy.

Flavio De Maio (F)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, 00168 Rome, Italy.
Dipartimento di Scienze biotecnologiche di base, cliniche intensivologiche e perioperatorie-Sezione di Microbiologia, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Giovanni Delogu (G)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, 00168 Rome, Italy.
Mater Olbia Hospital, 07026 Olbia, Italy.

Rita Berisio (R)

Institute of Biostructures and Bioimaging, IBB, CNR, 80134 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH